"Designing Growth Strategies is in our DNA"

Penile Implants Market Size, Share & Industry Analysis, By Type (Inflatable Penile Implants and Malleable Penile Implants), By Material (Silicone-Based Implants, Polyurethane-Based Implants, and Others), By Indication (Erectile Dysfunction, Gender-Affirming Surgery, Congenital Abnormalities, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

Last Updated: March 18, 2026 | Format: PDF | Report ID: FBI115772

 

Penile Implants Market Size and Future Outlook

Play Audio Listen to Audio Version

The global penile implants market size was valued at USD 732.4 million in 2025. The market is projected to grow from USD 774.4 million in 2026 to USD 1,266.8 million by 2034, exhibiting a CAGR of 6.3% during the forecast period.

Penile implants are medical devices that are surgically placed inside the penis to help men with severe erectile dysfunction (ED) achieve an erection. These devices are usually recommended when medicines or other treatments do not work. There are different types of implants, but inflatable models are the most commonly used because they provide a more natural experience. The market growth is attributed to the rising prevalence of erectile dysfunction. In addition, other factors such as aging, diabetes, obesity, and lifestyle habits are also projected to boost market growth during the forecast period. Further, growing awareness about penile implants, coupled with technological advancements, is also projected to augment segment growth.

  • For instance, according to data published by The Johns Hopkins University, in 2025, an estimated 322 million people will have erectile dysfunction across the globe.  

Furthermore, many key industry players, such as Boston Scientific Corporation, Coloplast A/S, Zephyr Surgical Implants AG, Rigicon, Inc., and Promedon S.A., operating in the market, are focusing on developing various innovative technologies to offer better products with improved accuracy and efficiency.

PENILE IMPLANTS MARKET TRENDS

Growing Preference for Inflatable Implant Systems is One of the Important Trends Observed in the Market

The market is witnessing an increasing preference for inflatable penile implants. These devices offer a more natural look and feel than simpler alternatives. In addition, these implants also allow better control and patient satisfaction. Manufacturers are improving pump design, durability, and ease of use, which is encouraging adoption. As clinical outcomes and patient confidence improve, the market is steadily shifting toward advanced inflatable systems.

  • For instance, in May 2022, the American Urological Association encouraged the adoption of inflatable penile implants by updating its guidelines.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Prevalence of Erectile Dysfunction to Accelerate Market Growth

The rising prevalence of erectile dysfunction is prominently driving the penile implants market growth. In addition, growth in the factors responsible for causing erectile dysfunction, such as aging, diabetes, heart disease, and obesity, is also estimated to have a positive impact on the market. Moreover, lifestyle stress, smoking, and sedentary habits also contribute to the condition. When oral medications fail, penile implants become an effective long-term treatment option. As the number of men seeking reliable solutions increases, demand for penile implants continues to grow across major healthcare markets.

MARKET RESTRAINTS

High Procedure Cost and Limited Awareness to Deter Market Growth

Penile implant surgery can be expensive, and insurance coverage varies across regions. Many patients are unaware that implants are available or assume the procedure is only for extreme cases. In addition, social stigma and hesitation to discuss sexual health also delay treatment decisions. In some developing regions, limited access to specialized urologists further reduces adoption.

MARKET OPPORTUNITIES

Expanding Men’s Health and Urology Services to Offer Lucrative Market Growth Opportunities

Increasing awareness of men’s health and urology services is expected to create a favorable opportunity for the global penile implants market. Healthcare facilities are expanding dedicated men’s health and urology programs. In addition, these centers actively screen and treat patients with erectile dysfunction, which increases referrals for advanced therapies such as penile implants. Moreover, telehealth consultations and patient education campaigns are also helping men seek treatment earlier. As healthcare providers focus more on quality of life and sexual wellness, the potential patient pool is expanding. This creates strong growth opportunities for manufacturers and providers in the penile implants market.

  • For instance, in January 2026, LifeRx announced the launch of a nationwide program for erectile dysfunction and hair loss. Through this program, the company plans to expand its customer base while providing better healthcare services.

MARKET CHALLENGES

Social Stigma and Delayed Treatment Decisions to Pose a Critical Challenge to Market Growth

Many patients hesitate to seek treatment for erectile dysfunction due to embarrassment or cultural stigma. Even when implants are clinically appropriate, men may delay surgery for years. This reduces the number of eligible patients who actually undergo the procedure. In addition, physicians must spend additional time on counseling and education to overcome these barriers. Until awareness and openness improve globally, social hesitation will remain a key challenge for market expansion.

Segmentation Analysis

By Type

Better Control and Ergonomics Offered by Inflatable Penile Implants to Boost Design and Inflatable Penile Implants Segment Growth

Based on type, the market is divided into inflatable penile implants and malleable penile implants.

The inflatable penile implants segment is anticipated to account for the largest penile implants market share. The benefits of inflatable penile implants, such as more natural erections and greater patient satisfaction drive segment growth. In addition, these devices allow users to control when and how long the erection lasts, which improves confidence and quality of life. Moreover, continual research & development activities are also projected to boost segment growth.

  • For instance, in June 2023, a group of researchers at King’s College Hospital announced the development of a new stimulator for inflatable penile prosthesis (IPP) surgery training.

The malleable penile implants segment is anticipated to rise with a CAGR of 3.7% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Material

Substantial Biocompatibility of Silicon-based Implants to Accelerate Segment Growth

Based on material, the market is segmented into silicone-based implants, polyurethane-based implants, and others.

In 2025, the silicone-based implants segment dominated the global market. Silicone is the most commonly used material because it is flexible, durable, and biocompatible. In addition, it provides a soft, natural feel that improves patient comfort. Moreover, silicone implants also have a long history of safe use in medical devices.

The polyurethane-based implants segment is anticipated to rise with a CAGR of 6.0% over the forecast period.  

By Indication

High Occurrence of Erectile Dysfunction to Boost Segment Growth

Based on indication, the market is segmented into erectile dysfunction, gender-affirming surgery, congenital abnormalities, and others.

In 2025, the erectile dysfunction segment dominated the global market. Erectile dysfunction is the primary reason penile implants are used. Most implant procedures are performed for men who do not respond to medication or other therapies. As ED prevalence rises globally, the number of patients eligible for implants is also increasing. Moreover, consolidation of healthcare infrastructure and emphasis on better treatment options are also projected to boost segment growth.  

  • For instance, in May 2025, a hospital in Abu Dhabi performed the UAE’s first penile implant on a young patient. The patient had an erectile dysfunction.

The gender-affirming surgery segment is anticipated to rise with a CAGR of 9.2% over the forecast period.  

By End-User

Higher Procedure Volume in Hospitals to Accelerate Segment Growth

Based on end-user, the market is segmented into hospitals, specialty clinics, and others.

In 2025, hospitals held the largest market share. Hospitals dominate the market because penile implant surgery requires specialized operating rooms and trained urologists. Most procedures are performed in hospital settings where post-operative care is available. Hospitals also handle complex cases and maintain the surgical infrastructure needed for implant procedures. Furthermore, the segment is set to hold 72.1% share in 2026.

In addition, the specialty clinics companies segment is projected to grow at a CAGR of 6.9% during the forecast period.

Penile Implants Market Regional Outlook

By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

North America Penile Implants Market Size, 2025 (USD Million)

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, at USD 325.4 million, and maintained the leading share in 2025, at USD 343.0 million. The market in North America is expected to increase due to the higher prevalence of erectile dysfunction and increasing awareness about penile implants.

U.S Penile Implants Market

Given North America’s strong contribution and the U.S. dominance in the region, the U.S. market is estimated to hit around USD 308.9 million in 2026, accounting for roughly 39.9% of global sales.

Europe

Europe is projected to record a growth rate of 6.0% in the coming years and reach a valuation of USD 217.1 million by 2026. The region is expected to see significant market growth driven by technological advancements and an increasing number of product launches.

U.K Penile Implants Market

The U.K. market in 2026 is estimated at around USD 35.2 million, representing roughly 4.5% of global revenues.

Germany Penile Implants Market

Germany’s market is projected to reach approximately USD 48.8 million in 2026, equivalent to around 6.3% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 113.6 million in 2026 and secure the position of the third-largest region in the market.

Japan Penile Implants Market

The Japanese market in 2026 is estimated at around USD 19.7 million, accounting for roughly 2.5% of global revenues.

China Penile Implants Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 37.7 million, representing roughly 4.9% of global sales.

India Penile Implants Market

The Indian market in 2026 is estimated at around USD 25.2 million, accounting for roughly 3.3% of global revenues.

Latin America and the Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 56.9 million in 2026. In the Middle East & Africa, the GCC is set to reach USD 9.1 million in 2026.

South Africa Penile Implants Market

The South African market is projected to reach around USD 3.8 million in 2026, representing roughly 0.48% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Rising Number of Product Launches and Technological Advancements by Key Players to Boost Market Progress

The global penile implants market has a semi-consolidated structure, with prominent players including Boston Scientific Corporation, Coloplast A/S, Zephyr Surgical Implants AG, Rigicon, Inc., and Promedon S.A. Rising product launches and technological advancements are driving significant market share for these companies.

  • For instance, in September 2024, CAMC is designated as the first center of excellence for Boston Scientific’s AMS 700 inflatable penile prosthesis. The organization is actively engaged in providing training and treatment options for patients who have erectile dysfunction.

Other notable players in the global market include Silimed Indústria de Implantes Ltda., Elist Medical, LLC, Surgiwear Limited, Bhagwati Surgicals, GT Urological, LLC. These companies are expected to prioritize collaborations to increase their global market share during the forecast period.

LIST OF KEY PENILE IMPLANTS COMPANIES PROFILED

  • Boston Scientific Corporation (U.S.)
  • Coloplast A/S (Denmark)
  • Zephyr Surgical Implants AG (Switzerland)
  • Rigicon, Inc. (U.S.)
  • Promedon S.A. (Argentina)
  • Silimed – Indústria de Implantes Ltda. (Brazil)
  • Elist Medical, LLC (U.S.)
  • TIMM Medical (U.S.)
  • Advin Health Care (India)
  • GT Urological, LLC (U.S.)
  • SBMED Produtos Médicos Ltda. (Brazil)

KEY INDUSTRY DEVELOPMENTS

  • June 2024: Himplant received FDA approval for its penile enhancement device. The device is used for penile health in severe trauma cases.
  • November 2023: Boston Scientific Corporation received FDA approval for its Tenacio pump component for its AMS 700 inflatable penile prosthesis. The treatment is designed for erectile dysfunction.
  • November 2023: Rigicon published a large dataset summary highlighting safety outcomes for the Rigi10 malleable penile prosthesis implanted worldwide.
  • March 2023: Coloplast announced production updates in its inflatable penile implants. The step was taken to offset the implant recalls, which affected the company's revenues.
  • February 2022: Aga Khan University Hospital in Kenya performed the country’s first penile implant surgery. It is the first surgery in the East African Region.

REPORT COVERAGE

The global penile implants market analysis includes a comprehensive study of the market size & forecast by all the market segments included in the report. It includes details on the market dynamics and market trends expected to drive the market over the forecast period. It provides information on key aspects, including technological advancements, the regulatory environment, and product launches. Additionally, it details partnerships, mergers & acquisitions, key industry developments, and investments by key regions. The global market research report also provides a detailed competitive landscape, including market share and profiles of key players.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

ATTRIBUTE DETAILS
Study Period 2021-2034
Base Year 2025
Estimated Year 2026
Forecast Period 2026-2034
Historical Period 2021-2024
Growth Rate CAGR of 6.3% from 2026-2034
Unit Value (USD Million)
Segmentation By Type, Material, Indication, End-User, and Region
By    Type
  • Inflatable Penile Implants
  • Malleable Penile Implants
By Material
  • Silicone-Based Implants
  • Polyurethane-Based Implants
  • Others
By Indication
  • Erectile Dysfunction
  • Gender-Affirming Surgery
  • Congenital Abnormalities
  • Others
By End-User
  • Hospitals 
  • Specialty Clinics
  • Others
By Region 
  • North America (By Type, Material, Indication, End-User, and Country)
    • U.S. 
      • By Type
    • Canada
      • By Type
  • Europe (By Type, Material, Indication, End-User, and Country/Sub-region)
    • Germany 
      • By Type
    • U.K.
      • By Type
    • France 
      • By Type
    • Spain 
      • By Type
    • Italy 
      • By Type
    • Scandinavia 
      • By Type
    • Rest of Europe
      • By Type
  • Asia Pacific (By Type, Material, Indication, End-User, and Country/Sub-region)
    • China 
      • By Type
    • Japan 
      • By Type
    • India 
      • By Type
    • Australia 
      • By Type
    • Southeast Asia 
      • By Type
    • Rest of Asia Pacific 
      • By Type
  • Latin America (By Type, Material, Indication, End-User, and Country/Sub-region)
    • Brazil
      • By Type
    • Mexico
      • By Type
    • Rest of Latin America
      • By Type
  • Middle East & Africa (By Type, Material, Indication, End-User, and Country/Sub-region)
    • GCC
      • By Type
    • South Africa
      • By Type
    • Rest of Middle East & Africa
      • By Type


Frequently Asked Questions

According to Fortune Business Insights, the global market value stood at USD 732.4 million in 2025 and is projected to reach USD 1,266.8 million by 2034.

In 2025, the market value stood at USD 343.0 million.

The market is expected to grow at a CAGR of 6.3% over the forecast period.

By type, the inflatable penile implants segment is expected to lead the market.

The rising prevalence of erectile dysfunction and the growing number of product launches are driving market expansion.

Boston Scientific Corporation, Coloplast A/S, Zephyr Surgical Implants AG, Rigicon, Inc., and Promedon S.A. are the major players in the global market.

North America dominated the market in 2025.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2021-2034
  • 2025
  • 2021-2024
  • 110
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann